Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-27T01:58:56.395Z Has data issue: false hasContentIssue false

Severe extrapyramidal symptoms with fluvoxamine despite neuroleptics withdrawal

Published online by Cambridge University Press:  16 April 2020

P Thomas
Affiliation:
Department of Psychiatry,University of Lille II School of Medicine, 6 avenue du Pr Laguesse, 59037Lille, France
J Roche
Affiliation:
Department of Psychiatry,University of Lille II School of Medicine, 6 avenue du Pr Laguesse, 59037Lille, France
M Maron
Affiliation:
Department of Psychiatry,University of Lille II School of Medicine, 6 avenue du Pr Laguesse, 59037Lille, France
O Cotencin
Affiliation:
Department of Psychiatry,University of Lille II School of Medicine, 6 avenue du Pr Laguesse, 59037Lille, France
G Vaiva
Affiliation:
Department of Psychiatry,University of Lille II School of Medicine, 6 avenue du Pr Laguesse, 59037Lille, France
M Goudemand
Affiliation:
Department of Psychiatry,University of Lille II School of Medicine, 6 avenue du Pr Laguesse, 59037Lille, France

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the editor
Copyright
Copyright © Elsevier, Paris 1996

References

Arya, DExtrapyramidal symptoms with selective serotonin reuptake inhibitors Br J Psychiatry 1994; 165: 728733CrossRefGoogle ScholarPubMed
Coulter, DPillans, PFluoxetine and extrapyramidal side effects Am J Psychiatry 1995; 152: 122125Google ScholarPubMed
Crewe, HLennard, MTucker, GWoods, FHaddock, RThe effects of selective serotonine reuptake inhibitors on cytochrome P4502D6 activity in human liver microsomes Br J Clin Pharmacol 1992; 34: 262265CrossRefGoogle Scholar
Wils, VExtrapyramidal symptoms in a patient treated with fluvoxamine J Neurol Neurosurg Psychiatry 1992; 55: 330331CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.